Is Invesco S&P 500 Equal Weight Materials ETF (RSPM) a Strong ETF Right Now?
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 25 2024
0mins
Should l Buy FMC?
Source: NASDAQ.COM
Invesco S&P 500 Equal Weight Materials ETF Overview: Launched in 2006, the Invesco S&P 500 Equal Weight Materials ETF (RSPM) offers broad exposure to the materials sector with a low expense ratio of 0.40% and a year-to-date return of approximately 11.11%.
Investment Considerations: While RSPM aims to outperform the materials ETFs segment, investors may also consider other options like the Materials Select Sector SPDR ETF (XLB) and FlexShares Morningstar Global Upstream Natural Resources ETF (GUNR), which have lower expense ratios and larger asset bases.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy FMC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on FMC
Wall Street analysts forecast FMC stock price to rise
14 Analyst Rating
3 Buy
10 Hold
1 Sell
Hold
Current: 14.790
Low
13.00
Averages
19.08
High
28.00
Current: 14.790
Low
13.00
Averages
19.08
High
28.00
About FMC
FMC Corporation is a global agricultural sciences company engaged in providing farmers solutions that increase the productivity and resilience of their land. The Company’s crop protection solutions, including biologicals, crop nutrition, digital and precision agriculture, enable growers and crop advisers to address their challenges economically while protecting the environment. Its portfolio consists of three major pesticide categories: insecticides, herbicides and fungicides. The majority of its product lines consist of insecticides and herbicides, and it has a portfolio of fungicides mainly used in high-value crop segments. Its insecticides are used to control a wide spectrum of pests, while its herbicide portfolio primarily targets a large variety of difficult-to-control weeds. In addition, it is also investing in its Plant Health program, which includes biologicals, crop nutrition, and seed treatment products. Biological technologies serve as complements to its synthetic products.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
FMC Sells Indian Subsidiary for $252 Million
- Transaction Value: FMC has signed an agreement to sell FMC India Private Limited to Crystal Crop Protection for $252 million, subject to customary adjustments for cash, debt, and working capital, with the deal expected to close by the end of 2026, highlighting FMC's strategic focus on resource allocation.
- Market Strategy Shift: This sale is part of FMC's decision in 2025 to divest its crop protection commercial business in India, aiming to engage in the Indian market through a new go-to-market strategy while concentrating resources on the highest growth opportunities globally, indicating the company's responsiveness to market dynamics.
- Ongoing Support: FMC will continue to receive cash flows from the Indian business operations until the closing of the transaction, ensuring business stability during the transition period, while supporting Crystal Crop's growth through a supply agreement, reflecting FMC's long-term commitment to the Indian market.
- Innovation and Collaboration: Crystal Crop will acquire FMC's commercial operations and brand licenses in India, expected to accelerate innovation in both chemical and biological domains, further enhancing the partnership with FMC and improving access to innovative products for Indian farmers, showcasing the synergistic effects in the market.
See More
FMC to Sell India Business for $252M to Crystal Crop Protection
- Transaction Value: FMC announced the sale of its India business to Crystal Crop Protection for $252 million, subject to working capital and regulatory adjustments, with the deal expected to close by the end of 2026, reflecting the company's decisive action in strategic restructuring.
- Strategic Focus: FMC plans to exit its India crop protection business by July 2025, aiming to concentrate resources on faster-growing global opportunities, indicating the company's keen awareness of market dynamics and proactive positioning for future growth.
- Debt Management: FMC intends to use the full proceeds from this transaction to reduce debt, which is expected to improve the company's financial health while continuing to support its R&D and global manufacturing operations in India, enhancing its competitive edge in the market.
- Asset Transfer: Under the agreement, Crystal Crop Protection will acquire FMC India's commercial operations, key brands, supply agreements, workforce, and access to FMC's future product pipeline in India, further solidifying its position in the local market.
See More
FMC Sells Indian Subsidiary for $252 Million
- Transaction Amount and Context: FMC Corporation has signed a definitive agreement to sell FMC India to Crystal Crop Protection for $252 million, which will provide FMC with cash flow to support resource allocation towards its highest-growth opportunities globally.
- Market Strategy Shift: This divestiture is part of FMC's strategic transformation announced in July 2025, aimed at maintaining a presence in the Indian market through a new go-to-market approach while focusing on high-growth areas worldwide.
- Transaction Details and Impact: The transaction is expected to close by the end of 2026, with FMC continuing to receive cash flow from the Indian business until closing, thereby enhancing its financial stability during the transition.
- Future Collaboration Outlook: Crystal Crop will acquire FMC's commercial operations and brand licenses in India, while FMC will support Crystal's growth through a supply agreement, highlighting the potential for long-term collaboration in agricultural technology.
See More
FMC Corporation Q1 2026 Earnings Call Insights
- Sales Performance Overview: FMC reported Q1 sales of $762 million, a 4% decline year-over-year, yet a 1% increase on a like-for-like basis after excluding India, demonstrating resilience amid challenging market conditions.
- Debt Management Plan: The company aims to reduce approximately $1 billion in debt during 2026 and expects to sign a definitive agreement for the sale of its India commercial business in May, which will help improve financial health and reduce leverage.
- Product Strategy Shift: FMC is transitioning production from high-cost plants to lower-cost sources in Asia, with completion expected by Q1 2027, thereby enhancing overall production efficiency and reducing costs.
- Future Outlook: The company anticipates Q2 revenue between $850 million and $900 million, with adjusted earnings per share expected to range from $0.16 to $0.26, maintaining full-year guidance despite uncertainties related to Iran and tariffs.
See More
FMC (FMC) Q1 2026 Earnings Call Transcript
See More
FMC STOCK RISES 11.4% FOLLOWING STRONG Q1 REVENUE AND SMALLER-THAN-EXPECTED LOSS
Revenue Performance: The company reported a revenue increase of 1.4% after exceeding expectations in Q1.
Losses: Despite the revenue beat, the losses were narrower than anticipated.
See More
FMC Sells Indian Subsidiary for $252 Million
- Transaction Value: FMC has signed an agreement to sell FMC India Private Limited to Crystal Crop Protection for $252 million, subject to customary adjustments for cash, debt, and working capital, with the deal expected to close by the end of 2026, highlighting FMC's strategic focus on resource allocation.
- Market Strategy Shift: This sale is part of FMC's decision in 2025 to divest its crop protection commercial business in India, aiming to engage in the Indian market through a new go-to-market strategy while concentrating resources on the highest growth opportunities globally, indicating the company's responsiveness to market dynamics.
- Ongoing Support: FMC will continue to receive cash flows from the Indian business operations until the closing of the transaction, ensuring business stability during the transition period, while supporting Crystal Crop's growth through a supply agreement, reflecting FMC's long-term commitment to the Indian market.
- Innovation and Collaboration: Crystal Crop will acquire FMC's commercial operations and brand licenses in India, expected to accelerate innovation in both chemical and biological domains, further enhancing the partnership with FMC and improving access to innovative products for Indian farmers, showcasing the synergistic effects in the market.
See More
FMC to Sell India Business for $252M to Crystal Crop Protection
- Transaction Value: FMC announced the sale of its India business to Crystal Crop Protection for $252 million, subject to working capital and regulatory adjustments, with the deal expected to close by the end of 2026, reflecting the company's decisive action in strategic restructuring.
- Strategic Focus: FMC plans to exit its India crop protection business by July 2025, aiming to concentrate resources on faster-growing global opportunities, indicating the company's keen awareness of market dynamics and proactive positioning for future growth.
- Debt Management: FMC intends to use the full proceeds from this transaction to reduce debt, which is expected to improve the company's financial health while continuing to support its R&D and global manufacturing operations in India, enhancing its competitive edge in the market.
- Asset Transfer: Under the agreement, Crystal Crop Protection will acquire FMC India's commercial operations, key brands, supply agreements, workforce, and access to FMC's future product pipeline in India, further solidifying its position in the local market.
See More
FMC Sells Indian Subsidiary for $252 Million
- Transaction Amount and Context: FMC Corporation has signed a definitive agreement to sell FMC India to Crystal Crop Protection for $252 million, which will provide FMC with cash flow to support resource allocation towards its highest-growth opportunities globally.
- Market Strategy Shift: This divestiture is part of FMC's strategic transformation announced in July 2025, aimed at maintaining a presence in the Indian market through a new go-to-market approach while focusing on high-growth areas worldwide.
- Transaction Details and Impact: The transaction is expected to close by the end of 2026, with FMC continuing to receive cash flow from the Indian business until closing, thereby enhancing its financial stability during the transition.
- Future Collaboration Outlook: Crystal Crop will acquire FMC's commercial operations and brand licenses in India, while FMC will support Crystal's growth through a supply agreement, highlighting the potential for long-term collaboration in agricultural technology.
See More
FMC Corporation Q1 2026 Earnings Call Insights
- Sales Performance Overview: FMC reported Q1 sales of $762 million, a 4% decline year-over-year, yet a 1% increase on a like-for-like basis after excluding India, demonstrating resilience amid challenging market conditions.
- Debt Management Plan: The company aims to reduce approximately $1 billion in debt during 2026 and expects to sign a definitive agreement for the sale of its India commercial business in May, which will help improve financial health and reduce leverage.
- Product Strategy Shift: FMC is transitioning production from high-cost plants to lower-cost sources in Asia, with completion expected by Q1 2027, thereby enhancing overall production efficiency and reducing costs.
- Future Outlook: The company anticipates Q2 revenue between $850 million and $900 million, with adjusted earnings per share expected to range from $0.16 to $0.26, maintaining full-year guidance despite uncertainties related to Iran and tariffs.
See More
FMC (FMC) Q1 2026 Earnings Call Transcript
See More
FMC STOCK RISES 11.4% FOLLOWING STRONG Q1 REVENUE AND SMALLER-THAN-EXPECTED LOSS
Revenue Performance: The company reported a revenue increase of 1.4% after exceeding expectations in Q1.
Losses: Despite the revenue beat, the losses were narrower than anticipated.
See More
